Complement and C4 null alleles in severe chronic adult periodontitis

Scandinavian Journal of Immunology

Volumn 65, Issue 2, 2007, Pages 176-181

  Seppanen M ^a   Lokki, M L ^b   Notkola, I L ^c   Mattila, K ^d   Valtonen, V ^a   Nieminen, A ^e   Vesanen, M ^f   Asikainen, S ^g   Meri, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Finnish Information Centre for Register Research   (Finland)

^d Porvoo Hospital   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Helsinki Clinic of Dentistry Ltd   (Finland)

^g UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; ALLOTYPE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEFICIENCY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEMOLYSIS; HUMAN; MALE; NULL ALLELE; PERIODONTITIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMPLEMENT C1; COMPLEMENT C4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS;

EID: 33846634248     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01886.x     Document Type: Article

References (46)

1. Armitage GC. Classifying periodontal diseases - a long-standing dilemma. Periodontol 2000 2002;30:9-23.
2. Asikainen S, Chen C. Oral ecology and person-to-person transmission of actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 2000 1999;20:65-81.
3. Travis J, Banbula A, Potempa J. The role of bacterial and host proteinases in periodontal disease. Adv Exp Med Biol 2000;477:455-65.
4. Yun PL, DeCarlo AA, Hunter N. Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis. Infect Immun 1999;67:2986-95.
5. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000;24:153-92.
6. Mezyk-Kopec R, Bzowska M, Potempa J et al. Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis. Infect Immun 2005;73:1506-14.
7. Attstrom R, Laurel AB, Lahsson U, Sjoholm A. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. J Periodontal Res 1975;10:19-27.
8. Schenkein HA, Genco RJ. Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol 1977;48:772-7.
9. Schenkein HA, Genco RJ. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid. J Periodontol 1977;48:778-84.
10. Monefeldt K, Helgeland K, Tollefsen T. In vitro cleavage of serum complement protein C3: a comparison between patients with adult periodontitis and periodontally healthy persons. J Clin Periodontol 1995;22:45-51.
11. Schenkein HA. Finding genetic risk factors for periodontal diseases: is the climb worth the view? Periodontol 2000 2002;30:79-90.
12. Kinane DF, Shiba H, Hart TC. The genetic basis of periodontitis. Periodontol 2000 2005;39:91-117.
13. Kobayashi T, Westerdaal NA, Miyazaki A et al. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect Immun 1997;65:3556-60.
14. Deas DE, Mackey SA, McDonnell HT. Systemic disease and periodontitis: manifestations of neutrophil dysfunction. Periodontol 2000 2003;32:82-104.
15. Carlsson G, Wahlin YB, Johansson A et al. Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol 2006;77:744-51.
16. Takashiba S, Naruishi K. Gene polymorphisms in periodontal health and disease. Periodontol 2000 2006;40:94-106.
17. Stein J, Reichert S, Gautsch A, Machulla HK. Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis? J Periodontal Res 2003;38:508-17.
18. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-66.
19. Blanchong CA, Zhou B, Rupert KL et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000;191:2183-96.
20. Seppanen M, Suvilehto J, Lokki ML et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol 2006;145:219-27.
21. Seppanen M, Meri S, Notkola IL et al. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis 2006;194:571-8.
22. Seppanen M, Lokki ML, Timonen T et al. Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections. Clin Infect Dis 2001;33:1604-7.
23. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-35.
24. Marcus D, Alper CA. Methods for allotyping complement proteins. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology, 3rd edn. Washington, DC: American Society for Microbiology, 1996:185-96.
25. Barba GM, Braun-Heimer L, Rittner C, Schneider PM. A new PCR-based typing of the Rodgers and Chido antigenic determinants of the fourth component of human complement. Eur J Immunogenet 1994;21:325-39.
26. Yang Y, Chung EK, Zhou B et al. Diversity in intrinsic strengths of the human complement system: Serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol 2003;171:2734-45.
27. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2004;18:9-13.
28. Arason GJ, Bodvarsson S, Sigurdarson ST et al. An age-associated decrease in the frequency of C4B*Q0 indicates that null alleles of complement may affect health or survival. Ann N Y Acad Sci 2003;1010:496-9.
29. Johnson RJ, Matthews JL, Stone MJ, Hurt WC, Newman JT. Immunopathology of periodontal disease. I. Immunologic profiles in periodontitis and juvenile periodontitis. J Periodontol 1980;51:705-12.
30. Anil S, Remani P, Vijayakumar T, Joseph PA. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis. J Periodontol 1990;61:27-9.
31. Mattila KJ, Nieminen MS, Valtonen VV et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81.
32. Syrjanen J. Infection as a risk factor for cerebral infarction. Eur Heart J 1993;14 (Suppl. K):17-9.
33. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998;97:2259-67.
34. Taskinen S, Kovanen PT, Jarva H, Meri S, Pentikainen MO. Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem J 2002;367:403-12.
35. Ajwani S, Mattila KJ, Narhi TO, Tilvis RS, Ainamo A. Oral health status, C-reactive protein and mortality - a 10 year follow-up study. Gerodontology 2003;20:32-40.
36. Kramer J, Rajczy K, Hegyi L et al. C4B*Q0 allotype as risk factor for myocardial infarction. BMJ 1994;309:313-4.
37. Nityanand S, Truedsson L, Mustafa A, Bergmark C, Lefvert AK. Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease. J Clin Immunol 1999;19:406-13.
38. Lokki ML, Koskimies SA. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics 1991;34:242-6.
39. Truedsson L, Gullstrand B, Jonsson T, Klint C. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes. Exp Clin Immunogenet 1995;12:66-73.
40. Chisikovsky J, Toto PD, Gargiulo AW. C1q and C4 detection on bacterial plaque organisms. J Periodontol 1982;53:688-92.
41. Niekrash CE, Patters MR. Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy. J Periodontal Res 1985;20:268-75.
42. Patters MR, Niekrash CE, Lang NP. Assessment of complement cleavage in gingival fluid during experimental gingivitis in man. J Clin Periodontol 1989;16:33-7.
43. Helakorpi S, Patja K, Prattala R, Uutela A. Health Behaviour and Health among the Finnish Adult Population, Spring 2005. Helsinki: Publications of the National Public Health Institute, 2005: 1-202. Available at: http://www.ktl.fi/attachments/suomi/julkaisut/julkaisusarja_b/2005/2005b18.pdf, accessed 2 October 2006.
44. Hauptmann G, Tappeiner G, Schifferli JA. Inherited deficiency of the fourth component of human complement. Immunodefic Rev 1988;1:3-22.
45. Szalai C, Fust G, Duba J et al. Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet 2002;39:46-51.
46. Yu CY, Whitacre CC. Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol 2004;25:694-9.